MCRS2 represses the transactivation activities of Nrf1 by Wu, Jia-Long et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
MCRS2 represses the transactivation activities of Nrf1
Jia-Long Wu†1, Young-Sun Lin†2, Chi-Chiang Yang3, Yu-Jen Lin4, Shan-
Fu Wu1, Ying-Ting Lin5 and Chien-Fu Huang*6
Address: 1IBMS, Academia Sinica, Taipei 11529, Taiwan, R.O.C, 2Development Center for Biotechnology, Taipei 11529, Taiwan, R.O.C, 3School 
of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan, R.O.C, 4Department of Fashion Design & 
Management, Tainan University of Technology, Tainan, Taiwan, R.O.C, 5Department of Biotechnology, College of Life Sciences, Kaohsiung 
Medical University, Kaohsiung, Taiwan, R.O.C and 6Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan, 
R.O.C
Email: Jia-Long Wu - chaperon123@gmail.com; Young-Sun Lin - yslin1955@gmail.com; Chi-Chiang Yang - cyang@csmu.edu.tw; Yu-
Jen Lin - t30065@mail.tut.edu.tw; Shan-Fu Wu - sfwu801@yahoo.com.tw; Ying-Ting Lin - ytlin@kmu.edu.tw; Chien-
Fu Huang* - chienfu@isu.edu.tw
* Corresponding author    †Equal contributors
Abstract
Background: Nrf1 [p45 nuclear factor-erythroid 2 (p45 NF-E2)-related factor 1], a member of the CNC-bZIP (CNC
basic region leucine zipper) family, is known to be a transcriptional activator by dimerization with distinct partners, such
as Maf, FosB, c-Jun, JunD, etc. The transcriptional roles of CNC-bZIP family are demonstrated to be involved in globin
gene expression as well as the antioxidant response. For example, CNC-bZIP factors can regulate the expression of
detoxification proteins through AREs, such as expression of human gamma-glutamylcysteine synthetases (GCS),
glutathione S-transferases (GST), UDP-glucuronosyl transferase (UDP-GT), NADP (H) quinone oxidoreductase
(NQOs), etc. To further explore other factor(s) in cells related to the function of Nrf1, we performed a yeast two-hybrid
screening assay to identify any Nrf1-interacting proteins. In this study, we isolated a cDNA encoding residues 126–475
of MCRS2 from the HeLa cell cDNA library. Some functions of MCRS1 and its splice variant-MSP58 and MCRS2 have
been previously identified, such as transforming, nucleolar sequestration, ribosomal gene regulation, telomerase
inhibition activities, etc. Here, we demonstrated MCRS2 can function as a repressor on the Nrf1-mediated
transactivation using both in vitro and in vivo systems.
Results: To find other proteins interacting with the CNC bZIP domain of Nrf1, the CNC-bZIP region of Nrf1 was used
as a bait in a yeast two-hybrid screening assay. MCRS2, a splicing variant of p78/MCRS1, was isolated as the Nrf1-
interacting partner from the screenings. The interaction between Nrf1 and MCRS2 was confirmed in vitro by GST pull-
down assays and in vivo by co-immunoprecipitation. Further, the Nrf1-MCRS2 interaction domains were mapped to the
residues 354–447 of Nrf1 as well as the residues 314–475 of MCRS2 respectively, by yeast two-hybrid and GST pull-
down assays.  By immunofluorescence, MCRS2-FLAG was shown to colocalize with HA-Nrf1 in the nucleus and didn't
result in the redistribution of Nrf1. This suggested the existence of Nrf1-MCRS2 complex in vivo. To further confirm
the biological function, a reporter driven by CNC-bZIP protein binding sites was also shown to be repressed by MCRS2
in a transient transfection assay. An artificial reporter gene activated by LexA-Nrf1 was also specifically repressed by
MCRS2.
Conclusion: From the results, we showed MCRS2, a new Nrf1-interacting protein, has a repression effect on Nrf1-
mediated transcriptional activation. This was the first ever identified repressor protein related to Nrf1 transactivation.
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Background
Nrf1 (NF-E2 related factor1) belongs to the Cap'n'Collar-
basic leucine zipper proteins (CNC-bZIP). The CNC-bZIP
family is identified by its homology region, named the
CNC domain, immediately N-terminal to the bZIP
domain [1]. This family contains a basic domain interact-
ing with sequence-specific DNA and a leucine zipper
domain (bZIP) involved in protein-protein dimerization
[2-4]. The members of Cap'n'Collar (CNC) family contain
Nrf1, Nrf2, Nrf3, p45 NF-E2, Drosophila CNC protein, as
well as C. elegans Skn-1 [5-9]. There are two known tran-
scriptional roles of the CNC-bZIP family. First, they are
involved in globin gene expression. Transcriptional con-
trol of the human beta-globin gene cluster is mediated by
four DNase I hypersensitive sites (HS1–4) spanning
approximately 6–22 kb upstream of the epsilon-globin
gene [10-13]. A similar gene structure (HS-40) is also
present in alpha-globin gene expression [10,14,15]. The
locus control region (LCR) appears to be necessary for
high protein level expression from the entire globin gene
clusters. The LCRs contain a direct sequence repeats 5'-(A/
G)TGA(C/G)TCAGC(A/G)-3', which is the binding site
for CNC-bZIP transcription factors [16]. Second, they play
a role in the antioxidant response. The consensus antioxi-
dant response element (ARE) core sequence 5'-TGA(C/
G)NNNGC-3' shows remarkable similarity to the afore-
mentioned binding sequence for CNC-bZIP proteins. This
similarity has led to the proposal CNC-bZIP factors can
regulate detoxification proteins expression through AREs
[17-21], such as expression of human gamma-glutamyl-
cysteine synthetases (GCS), glutathione S-transferases
(GST), UDP-glucuronosyl transferase (UDP-GT), NADP
(H) quinone oxidoreductase (NQOs), etc.
Like the other members of CNC-bZIP factors, Nrf1 can
heterodimerize with small Maf proteins to bind the cis-
elements more efficiently [16,22]. The small Maf proteins,
including MafK, MafG and MafF, are identified by their
homology to the avian transforming retroviral oncogene,
v-maf with lacking of transactivation domains [23-25].
Transcriptional repression by Maf-Maf homodimers, yet
activation by Maf-Nrf heterodimers, is shown in LCR-reg-
ulated gene regions [22]. To further explore other factor(s)
in cells related to Nrf1, we performed a yeast two-hybrid
screening assay using the CNC-bZIP region of Nrf1 as a
bait to identify any Nrf1-interacting proteins. In this
study, cDNAs encoding residues 126–475 of MCRS2 (or
residues 185–534 of p78/MCRS1, or residues 113–462 of
MSP58 [26-28] were isolated from the HeLa cell cDNA
library. In this paper, we characterized the physical and
functional interactions between Nrf1 and MCRS2.
Some functions of MCRS1 and its splice variant-MSP58
and MCRS2 have been reported before, such as transform-
ing, nucleolar sequestration, ribosomal gene regulation,
and telomerase inhibition activities [28-32]. For example,
TOJ3, a protein with high structural similarity to MCRS1,
display transformation activity [32]. In addition, the
tumor suppressor gene PTEN suppresses the transforma-
tion activity of MCRS1 [30]. It was reported MSP58 can
relieve the repressor activity of Daxx, an adaptor protein
that links Fas signaling to the c-Jun NH2-terminal kinase
pathway by a nucleolar sequestration mechanism [31].
Further, MCRS2 is also shown to be involved in telomere
shortening by interacting with telomerase [28]. Although
these studies illustrates several functions of MCRS1/p78
and its splice variant, the roles of MCRS2 on Nrf1 transac-
tivation activity have not been previously identified. Here
we will show MCRS2 can function as a repressor on the
Nrf1-mediated transactivation.
Results
Identification of MCRS2 as a Nrf1-interacting protein
In searching for proteins specifically interacting with the
important domain of Nrf1, we screened a HeLa MATCH-
MAKER activation domain library (Clontech) using a chi-
meric protein construct composed of the CNC-bZIP
domain (residues 276–447) of Nrf1 fused to GAL4 DNA
binding domain as a bait [GAL4DB-Nrf1(276–447)].
Fusion protein GAL4DB-lamin and GAL4DB-Lef1▲N105
were also included in assays to remove possible false pos-
itive clones. Roughly 106 colonies were screened with this
yeast two-hybrid system. Among the clones identified and
sequenced, a few clones contained cDNA encoding the C-
terminal region of either MSP58 protein (residues 113–
462), p78/MCRS1 (residues 185–534), or MCRS2 (residues
126–475) [28]. To examine whether Nrf1 interacted with
full-length MCRS2, the interaction between Nrf1 and
MCRS2 was also confirmed in a yeast two hybrid system.
As summarized in Fig. 1A, MCRS2, consistent with the
data obtained with truncated versions of MCRS2, inter-
acted quite well with Nrf1 (276–447) (row 6). Control
experiments confirmed the specificity of the Nrf1-MCRS2
interactions: introducing plasmid pGAL4DB-Nrf1 (276–
447) alone into yeast produced no colony (row 4). Simi-
larly, no colony was observed upon co-transformation of
pGAL4DB-Nrf1 (276–447) with pGAL4AD-TCF4 (row 5),
which was the negative control. Thus, two conclusions
could be drawn from the above experiments. First, there
was a specific interaction between Nrf1 and MCRS2. Sec-
ond, the bZIP to C-terminus domain of Nrf1 was involved
in the binding to MCRS2.
Mapping the interaction domain between MCRS2 and 
Nrf1
Because MCRS2 displayed relatively high affinity toward
Nrf1, we set out to map the MCRS2-binding domain of
Nrf1 with a yeast two-hybrid system using GAL4AD-
MCRS2 and a panel of GAL4 DB-Nrf1 deletion constructs.
As summarized in Fig. 1B, the residues 276–447 of Nrf1BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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Figure 1 (see legend on next page)
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interact with MCRS2 (row 1). The CNC region of Nrf1 (res-
idues 276–330) failed to interact with MCRS2 (row 2).
While residue 331–447 of Nrf1, composed of the basic
region, the ZIP region and the most C-terminal region
contributed to the binding of MCRS2 (row 3). Thus, resi-
dues 354–447 of Nrf1, including the zipper region and the
most C-terminal region, constituted the minimal MCRS2-
binding domain (compare row 3 and 5 to row 4, 6, 7 and
8). These findings suggest the CNC region (compare row 1
to row 2 and 3) and basic region (compare row 3 to row 5
and 6) of Nrf1 were not required to interact with MCRS2.
Interestingly, although the residues 396–447 of Nrf1
encompassing the region C-terminal to the zipper of Nrf1
didn't bind directly to MCRS2 (row 8), they were abso-
lutely required for the interaction between Nrf1 and
MCRS2 (compare row 5 to row 7 and 8).
We also performed mapping of Nrf1-binding domain of
MCRS2 by yeast two-hybrid assay using a panel of various
deletion constructs of GAL4AD-MCRS2. As shown in Fig.
1C, the minimal MCRS2-interacting domain of Nrf1 (res-
idues 354–447) interacted with MCRS2 (row1) and C-ter-
minal region of MCRS2 spanning residue 254–475
(contain putative ZIP domain, coiled-coil domain, FHA
domain, and the most C-terminal region) interacted with
Nrf1 (row 3). The N-terminal region of MCRS2 (residues 1–
253) failed to interact with Nrf1 (row 2). Further, the min-
imal Nrf1-interacting domain of MCRS2 was mapped to
the residues 314–475 (contain the coiled-coil domain,
FHA, and the most C-terminal reagion), and the C-termi-
nus of MCRS2 (residues 433–475) was required for Nrf1-
MCRS2 interaction (row 5–7). Taken together, we con-
cluded the coiled-coil and FHA domain of MCRS2 were
indispensable for its interaction with Nrf1.
Interaction of Nrf1 with MCRS2 in vitro and in vivo
To test whether Nrf1 interacted with MCRS2 in vitro, vari-
ous affinity matrixes consisting of various deletion con-
structs of GST-Nrf1 or GST-MCRS2 fusion proteins as the
ligands were prepared. The S35-labled full-length protein
of either Nrf1 or MCRS2 was incubated with the matrix,
and the bound proteins were analyzed by SDS-PAGE. Fig.
2A shows, consistent with data obtained with the yeast
two-hybrid system (Fig. 1), MCRS2 (lane 4–6) bound to
GST-Nrf1 (1–447), GST-Nrf1 (331–447), and GST-Nrf1
(354–447). However, GST (lane 3) and GST-Nrf1 (354–
395) (lane 7) failed to be retained under the same experi-
mental conditions. Moreover, Nrf1 (331–447) had higher
affinity toward MCRS2 than Nrf1 (354–447) did (com-
pare lane 5 with lane 6). The data agree with the results
obtained from the yeast two-hybrid experiments (Fig. 1).
In addition, the interactions between S35-labled Nrf1 and
various deletion constructs of GST-MCRS2 fusion protein
were also demonstrated in the same way (Fig. 2B). Nrf1
failed to interact with GST (lane 3) and GST-MCRS2 (314–
373) (lane 7). In contrast, Nrf1 interacted with full-length
MCRS2 and C-terminal of MCRS2 (residues 314–475)
(lane 4 and lane 5). Then S35-Nrf1 showed a decreasing
affinity toward the C-terminal region of MCRS2 (lane 5–
7). The results were consistent with the data obtained
from yeast two hybrid results (Fig. 2B).
To determine whether MCRS2 associates with Nrf1 in
mammalian cells, plasmids expressing MCRS2-FLAG and
HA-Nrf1 fusion protein were co-transfected into 293 cells
for co-immunoprecipitation assay study. Cell extracts
were prepared from transfected cells and then immuno-
precipitated with an antibody against FLAG. As summa-
rized in Fig. 3, Nrf1 only co-precipitated in the presence of
MCRS2 by an anti-FLAG antibody but not in the presence
of a preimmune serum (top panel, compare lane 4 with lane
7). No Nrf1 co-precipitation was noted when cells overex-
pressed Nrf1 plus Nrf1-unrelated protein β-catenin
(S33Y) (lane 5). No foxp2 co-precipitation was observed
when cells overexpressed MCRS2 and unrelated Foxp2
Interaction of MCRS2 with Nrf1 Figure 1 (see previous page)
Interaction of MCRS2 with Nrf1. Left column, GAL4 DNA binding domain (amino acids 1–147) hybrids. Middle column, 
GAL4 activation domain (amino acids 768–881) hybrids. Right column, yeast colony color after transformation. Minus (-) indi-
cated no yeast colony was noted following growth incubation. A, characterization of the interaction between Nrf1 and 
MCRS2. Left column, the GAL4 DNA-binding domain (GAL4BD) hybrid. Middle column, the GAL4 DNA-activation domain 
(GAL4AD) hybrid. Right column, yeast colony color after transformation. The lamin, LEF1ΔN105, and TCF4 constructs in this 
experiment were used for the negative control. B, The C terminus of Nrf1 was required and sufficient for the interaction with 
MCRS2. Left column, the various GAL4DB-Nrf1 deletion derivatives. Middle column, GAL4AD-MCRS2. Right column, yeast col-
ony color after transformation. The Nrf1 fragments fused to the GAL4 DNA binding domain are indicated on the left of the 
diagrams. The relative positions of CNC, basic, and ZIP domains of Nrf1 are also depicted. C, The C terminus of MCRS2 was 
required and sufficient for the interaction with Nrf1. Left column, GAL4DB-Nrf1 (354–477). Middle column, the various 
GAL4AD-MCRS2 deletion derivatives, Right column, yeast colony color after transformation. The MCRS2 fragments fused to 
GAL4 activation domain are shown in the middle of the diagrams. The relative positions of putative ZIP, coiled-coil, FHA 
domains of MCRS2 are also depicted. D, The photograph of colony formation came from the results of A. The labels of Figure 
1D were the same labels of A.BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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(lane 6). From this data, we concluded Nrf1 and MCRS2
formed a complex in vivo.
Colocalization of Nrf1 and MCRS2 in the nucleus
We attempted to correlate our findings of a Nrf1-MCRS2
complex in living cells by analyzing the subcellular distri-
bution of these two proteins. In previous studies, exoge-
nously expressed Nrf1 was found to be localized chiefly in
the nucleus [16]. MCRS2 was also reported to be co-local-
ized with LTPS/PinX1 in the nucleus, especially in nucle-
oli [28]. We used the HA-Nrf1 and MCRS2-FLAG fusion
proteins as well as corresponding fluorescent antibodies
as the dynamic fluorescent markers to facilitate detection
of the two partner's subcellular distribution (Fig. 4).
Immunofluorescence detection of HA-Nrf1 (green) and
MCRS2-FLAG (red) was obtained by rabbit anti-HA and
mouse anti-FLAG antibodies and followed by the corre-
sponding species-specific labelled antibody. In our study,
Nrf1 was colocalized with MCRS2 in the nucleus (Fig. 4,
panel h and p). Co-expression of Nrf1 and MCRS2 did not
cause cellular redistribution of these two proteins (com-
pare lane 1–2 with lane 3). These results taken together
strongly suggest Nrf1-MCRS2 complex can exist in vivo
and MCRS2 might participate physiologically in Nrf1-
mediated transcriptional activity.
Repression of transactivational activity of Nrf1 by MCRS2
Because Nrf1 interacted with MCRS2 in vivo (Fig. 3 and
Fig. 4), it was important to ask whether the transcriptional
activity of Nrf1 was modulated by MCRS2. To address this
question, two complementary experiments were per-
formed. First, a reporter activity driven by HS40 element
of α-globin Locus Control Region, containing the CNC-
bZIP protein binding sites, was measured under the influ-
ence of MCRS2. As illustrated in Fig. 5, transcription of the
reporter, HS40-TK-Luc, was inhibited by MCRS2 but not
by another unrelated protein β-catenin (S33Y) (compare
lane 2–4, white bar). Substitution of the Nrf1 binding sites
with the minimal TK promoter rendered the resultant
reporter, TK-Luc, unresponsive to MCRS2 (compare lane 3
and lane 4, black bar). We concluded the MCRS2-mediated
repression depended on the presence of the NF-E2 bind-
ing sites (compare black bar with  white bar). Second,
because multiple CNC-bZIP factors can interact with the
NF-E2 site, the identity of CNC-bZIP factors involved in
the repression was determined by measuring the effect of
MCS2 on the transcription activities of LexA-CNCbZIP
fusion proteins. As shown in Fig. 6, the transcriptional
activity of the LexA-Nrf1 was largely reduced in the pres-
ence of MCRS2 in 293 T cells (compare lanes 6-7). The
reduction was specific, because MCRS2 had little effect on
LexA-VP16 and LexA-NFE2. Based on data obtained from
the aforementioned experiments, we believe a direct inter-
action between Nrf1 and MCRS2 was required for the
observed specific repression.
Discussion
Based on the results from yeast two-hybrid and immuno-
precipitation assays presented here, we believe MCRS2
interacted with Nrf1 and suppressed Nrf1-mediated tran-
scriptional activity. Since Nrf1-mediated transactivation
plays an important role in antioxidant response and
embryo development, its activities need to be well con-
trolled [17,18,20,33,34]. Small Maf protein is a well-
known interaction partner of Nrf1. Nrf1/Maf heterodimer
recognizes the NF-E2/AP1-like motif and activates down-
stream gene expression [16,22]. Other Nrf1-interacting
proteins such as AP1 proteins (c-Jun, JunB, and JunD)
also regulate antioxidant response element (ARE)-medi-
ated detoxifying enzymes expression in response to anti-
oxidants and xenobiotics [17]. Until now there has never
been any report of a protein repressing the Nrf1-mediated
transactivation. Here, we found MCRS2 has a high ten-
dency to repress Nrf1-mediated transactivation.
CNC-bZIP factors binding site is also reportedly involved
in the transcriptional regulation of many cellular protec-
tive and antioxidant genes [17-21]. Thus, by interacting
In vitro direct interaction of Nrf1 with MCRS2 Figure 2 (see previous page)
In vitro direct interaction of Nrf1 with MCRS2. A, binding of MCRS2 by various GST-Nrf1 deletion mutants is shown. 
The GST protein bead used is indicated above for each track of the autoradiogram. Top panel, in vitro translated MCRS2 was 
incubated with GST (lane 3) or GST-Nrf1 derivatives (lanes 4–7) beads at 4°C for 2 hours and then was eluted with 0.1 M 
reduced glutathione. The autoradiography from the eluted supernatants was separated on a 10% SDS-PAGE gel. Lane 1 indi-
cates 1/20 labelled MCRS2 (S35-MCRS2). Middle panel, the same amounts of purified GST (lane 3) and GST-Nrf1 derivatives 
(lanes 4–7) were used in a GST pull-down assay, separated on a 10% SDS-PAGE gel, and then stained. Bottom panel, diagram of 
the purified GST and GST-Nrf1 derivatives. B, binding of Nrf1 by various GST- MCRS2 deletion mutants is shown. The GST 
protein bead used is indicated above each track of the autoradiogram. Top panel, in vitro translated Nrf1 was incubated with 
GST (lane 3) or GST-MCRS2 derivatives (lanes 4–7) beads at 4°C for 2 hours and was then eluted with 0.1 M reduced glutath-
ione. The autoradiography from the eluted supernatants was separated on a 10% SDS-PAGE gel. Lane 1 indicated 1/60 labelled 
Nrf1 (S35-Nrf1). Middle panel, the same amounts of purified GST (lane 3) and GST-MCRS2 derivatives (lanes 4–7) were used in 
GST pull-down assay, separated on a 10% SDS-PAGE gel, and then stained. Bottom panel, diagram of the purified GST and GST-
MCRS2 derivatives.BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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Nrf1 interacts with MCRS2 in vivo Figure 3
Nrf1 interacts with MCRS2 in vivo. Top row, the transfected expression plasmids are indicated. Total cell extracts were 
prepared from the cells transfected with the indicated expression plasmids and were then incubated with an antibody against 
FLAG epitope (lane 1–6) or a pre-immune serum (lane 7). The resulting co-immunoprecipitates were separated on a 10% SDS-
PAGE gel and probed with an antibody against HA epitope. The control experiments (middle and bottom rows) were done using 
the same cell extracts as the top row to indicate the transfected cell indeed express FLAG fusion protein (middle row) and HA 
fusion protein (bottom row) and were detected by anti-FLAG or anti-HA antibody, respectively. IgG HC, immunoglobulin heavy 
chain. WB, western blot. PS, pre-immune serum.BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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Co-localozation of Nrf1 and MCRS2 Figure 4
Co-localozation of Nrf1 and MCRS2. 293 (panel a-h) and H1299 cells (panel i-p) were transfected with plasmid constructs 
expressing either HA-Nrf1 alone (panel a, d, i and l), MCRS2-FLAG alone (panel b, e, j and m), or HA-Nrf1 and MCRS2-FLAG 
together (panel c, f, g, h, k, n, o and p). After 24 hours, cells were fixed and stained with the antibodies. The antibodies used 
were the M2 monoclonal antibody against FLAG-tagged MCRS2 and the rabbit polyclonal anti-HA antibody against the HA-
tagged Nrf1. The cells were viewed with the phase-contrast microscope (panel a-c and i-k). The green signal (αHA-Nrf1) was 
obtained with a FITC-conjugated secondary antibody under a confocal microscope (panel d, f, l and n). The red signal 
(αMCRS2-FLAG) was obtained with a Rhodamin-conjugated secondary antibody under confocal microscope (panel e, g, m and 
o). The merged images (panel h and p) showed the co-localization of Nrf1 and MCRS2.BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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Figure 5 (see legend on next page)
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with Nrf1, MCRS2 may shift the balance between activa-
tion and repression of these regulatory genes and result in
the modulation such as detoxifying mechanisms. In fact,
we believe the promoters of NQO1 and other detoxifying
enzyme genes are possibly regulated by Nrf1/MafG; and
the differential effects of Nrf2 and Nrf1 with small Maf
proteins on NQO1 gene activation remain unknown.
Therefore, the unpredictable interaction between MCRS2
and Nrf1 may play some role in the upper issue.
The c-terminus (719–772) of the long Nrf1 behind the
zipper domain is the Neh3 domain of Nrf1. This domain
is required but not sufficient for interaction with MCRS2
(containing coiled-coil domain, FHA domain, and C-ter-
minus) in the yeast two-hybrid system. The specific inter-
action between MCRS2 and the Neh3 domain appears to
be important for the interaction with Nrf1 and suggests
Neh3 of Nrf1 may be involved in recruiting accessory pro-
teins or serve to bridge the transcription factor to the
active transcription apparatus [35]. The precise mecha-
nism of the interactions between Neh3 of Nrf2 and CHD6
leading to gene transcription has been demonstrated but
is not fully understood by a previous study (Nioi et al,
2005). The findings of that paper provide strong evidence
suggesting the Neh3 domain may act as a TAD. The activ-
ity of the Neh3 domain relies on the VFLVPK motif, which
is chiefly hydrophobic in nature and could be a site of
interaction with a novel partner molecule. Further,
sequences from N terminal to the VFLVPK motif of Neh3
domains are also very highly conserved among the CNC-
bZIP family and critical for the interaction of Nrf1 with
MCRS2. The interaction of MCRS2 with other members of
the CNC-bZIP family needs to be further explored. The
critical F591 residue of Nrf2 Neh3 domain is changed to
L748 residue on Nrf1. It is worth exploring whether this
change influences the interaction between Nrf1 and
CHD6 or determines the different interactions of Nrf1
with MCRS2 and CHD6. The Neh3 domain functions as a
protein-protein interaction module to facilitate the
recruitment of putative coactivator proteins, such as
MCRS2, to Nrf1-dependent genes. This phenomenon is
similar to the interaction between CHD6 and Nrf2, but
MCRS2 negatively regulates Nrf1, while CHD6 positively
regulated Nrf2. It is an interesting question of whether
Nrf1 could be regulated by both MCRS2 and CHD6 and if
the contrast effects of MCRS2 and CHD6 influence Nrf1-
mediated ARE-driven gene expression.
The Nrf1 protein utilized in this study is slightly shorter
than TCF11 and contains 447 amino acids without its N-
terminal domain. The protein was obtained by alternative
splicing of mRNA. In particular, the peptide sequence
GLLQFTILLSLIGVRVD termed the NHB1 (N-terminal
homology box 1) found between residues 11 and 27 of
Nrf1 shares 35% of its identity with the MLLSV-
PLLLGLLGLAAA leader sequence found between residues
1 and 17 of mouse calreticulin. The latter sequence has
been implicated in the translocation of calreticulin into
the endoplasmic reticulum [36,37]. The data of Zhang et
al (2006) has shown artificial Nrf2 with this N-terminal
domain can anchor on endoplasmic reticulum and dis-
play less transactivation activity towards the ARE-reporter
gene than wild-type Nrf2, suggesting, targeting these bZIP
proteins to membranes inhibits their activity [36]. From
the data of Zhang et al, we also know Nrf1 can associate
with the endoplasmic reticulum and is not regulated by
Keap1, whereas Nrf2 does not associate with this
organelle and is regulated by Keap1. The two observations
suggest these two bZIP factors mediate adaptation to
redox stress in different subcellular compartments. We
found the interaction between Nrf1 and MCRS2 probably
played certain roles in redox stress. Our finding in this
paper could explain, at least in part, the distinct regulation
phenomona noted in the Nrf1 and Nrf2 KO mice.
Conclusion
In summary, we have shown the close interaction between
CNC-bZIP transcription factor Nrf1 and MCRS2. From
our study, the repression of Nrf1 transactivation by
MCRS2 is reported for the first time. The identification of
Keap1 (Kelch-like ECH-associated protein 1) as a repres-
sor of Nrf2 activity defines the current regulatory pathway
for Nrf2 activation [38-40]. Keap1 acts by directly interact-
ing with Nrf2 and preventing its nuclear accumulation
Transcription driven by NF-E2 binding sites is repressed by MCRS2 Figure 5 (see previous page)
Transcription driven by NF-E2 binding sites is repressed by MCRS2. Transient transfections were performed in 293 
cells using HS40-TK-Luc as a reporter. HS40-TK-Luc was constructed by inserting the HS40 element containing NF-E2 binding 
sites before the HSV-TK promoter of TK-Luc. Briefly, the cells were transiently transfected with luciferase reporter (0.2 μg), 
β-galactosidase reporter (0.05 μg), and the plasmid constructs expressing HA-Nrf1 (0.2 μg), MCRS2-FLAG (0.4 μg) and β-cat-
enin (S33Y)-FLAG (0.4 μg) as indicated. 36 hours after transfection, the activities of luciferase and β-galactosidase were deter-
mined as described under "Experimental procedures". Luciferase activity from transfected cells was normalized with the β-
galactosidase activity and expressed as relative luciferase activities compared with the control (lane 1, black bar). Error bars 
represent the mean ± S.D. from three independent determinations. β-catenin (S33Y)-FLAG in this experiment was used as the 
control for comparing the effects from MCRS2-FLAG. Other control experiments were also preceded as above, except the 
reporter was only driven by the HSV-TK promoter (black bar).BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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[38-40]. In this study, we find the new repressor-MCRS2
acts as a regulator on Nrf1 transcriptional activities and
the C-terminus of Nrf1 containing ZIP domain interacts
with MCRS2. We show MCRS2 and Nrf1 interact through
the ZIP domain of Nrf1 and the C-terminal region of
MCRS2 containing coiled-coil and FHA domain. Note,
the most C-terminus of Nrf1 and MCRS2 do not directly
bind to each other (row 8 of Fig 1B and row 7 of Fig 1C),
but it is absolutely required for this interaction. The FHA
domain in MCRS2 is well conserved [41-43] and presum-
ably mediates protein-protein interactions in some cellu-
lar processes. FHA domains are found almost exclusively
in nuclear proteins, which are linked to the control of
transcription, DNA repair, or cell-cycle progression [41-
43]. So the interaction between Nrf1 and MCRS2 may
play some important roles related to the repression of
Nrf1-related transcription.
Methods
Plasmid construction
For the yeast two-hybrid system, Nrf1 (276–447) and its
derivatives were cloned between the EcoRI and BamHI
sites of pAS2-1 (CLONTECH). MCRS2 and its derivatives
were cloned between the BamHI and XhoI sites of pACT2
(CLONTECH). For the bacterial protein expression con-
struct, GST-Nrf1 derivatives were cloned between EcoRI
and BamHI sites of pGEX-1 (Amersham Bioscience),
while GST-MCRS2 derivatives were cloned by inserting
the corresponding DNA fragment between BamHI and
EcoRI sites of pGEX-5X-1 (Amersham Pharmacia Bio-
tech). For mammalian expression and in vitro translation
constructs, the pcDNA3HA-Nrf1 was obtained by insert-
ing the Nrf1 cDNA between XbaI and EcoRI sites of
pcDNA3-HA (Invitrogen), which had a HA epitope linked
to the N-terminus of Nrf1 protein. pRK5F-MCRS2 was
cloned by inserting the MCRS2 cDNA between EcoRI and
XbaI sites of pRK5F (BD PharMingen), which had a FLAG
epitope on the C-terminus of MCRS2 protein. Full-length
MCRS2 cDNA was generated by nested PCR (polymerase
chain reaction) from fetal brain cDNA library (CLON-
TECH) using two pairs of primers: p78-FL (5'-ATCAC-
CAGTCTGACCTGAGCACCA-3'), p78-RL (5'-
TTTTTCCAGGAGCCTGAGTTCCCA-3'), p78-N-EcoRI (5'-
CCGGAATTCACATGACACGTGGCACCG-3'), P78-C-
XbaI (5'-GCTCTAGACTGTGGTGTGATCTTGGC-3'). For
the reporter assay, reporter tk-Luc was constructed by
replacing the BglII/HindIII fragment of pGL3-basic
(Promega) with the HSV-TK promoter DNA fragment
from the BglII/HindIII fragment of phRL-TK (Promega).
Reporter HS40-TK-Luc was formed by replacing the KpnI/
BglII fragment of reporter tkLuc with the fragment of
HS40 enhancer of α-globin locus control region (355 bp)
from the KpnI/BglII fragment of pGL3HS40α [44] pro-
vided kindly by Dr. Shen. Reporter pGL3-control-L6 was
constructed by inserting six LexA biding sites between the
BglII and HindIII sites of pGL3-control reporter
(Promega). LexA fusion protein expression plasmid
pLexA-Nrf1 has been described before [45,46]. CMV- LacZ
was constructed by inserting the LacZ gene between the
SmaI and BamHI sites of pRK5F (BD PharMingen).
Yeast two-hybrid screen
The DNA fragments encoding the C-terminal of Nrf1
(276–447), containing CNC and bZIP domain, was gen-
erated by PCR and subsequently inserted into pAS2-1 vec-
tor (Clontech) to produce GAL4DB-Nrf1 (276–447) bait.
The GAL4DB-Nrf1 (276–447) bait was used to screen
against human HeLa  MATCHMAKER cDNA library
(MATCHMAKER two-hybrid system; Clontech). Yeast
transformation was performed using a MATCHMAKER
GAL4 Two-Hybrid System 3 according to the manufac-
turer's instructions (Clontech). AH109 yeast strain was
simultaneously cotransformed with GAL4DB-Nrf1 (276–
447) bait and human HeLa MATCHMAKER cDNA library.
The library trasformants were then selected on SD agar
plate lacking leucine, tryptophan, adenine, and histidin.
The plasmids extracted from blue colonies, amplified in E.
Coli  MC1061P3 strain, and retransformed with either
GAL4DB-Nrf1 (276–447), GAL4DB-Lef1▲N105, or
GAL4DB-lamin to test the binding specificity. The plas-
mids screened out from the library and confirmed for the
interactions with Nrf1 (276–447) domain were then sub-
jected to DNA sequence analysis.
Nrf1-mediated transcriptional activation is repressed by MCRS2 Figure 6 (see previous page)
Nrf1-mediated transcriptional activation is repressed by MCRS2. A, MCRS2 mediates transcriptional repression on 
the transcriptional activity of LexA-Nrf1. Transient transfections were performed in 293 T cell using pGL3-control-L6 as the 
reporter containing six LexA-binding sites. The LexA-bZIP family fusion proteins and MCRS2 in each transfection are indicated 
below each track of the activities. Briefly, cells were transfected with pGL3-control-L6 reporter (0.2 μg), β-galactosidase 
reporter (0.1 μg), and either plasmid constructs expressing LexA (0.6 μg), LexA-Vp16 (0.6 μg), LexA-NFE2 (0.6 μg), or LexA-
Nrf1 (0.6 μg) with or without MCRS2 (0.5 μg) or β-catenin (S33Y) (0.5 μg) as indicated. 36 hours after transfection, the activity 
of luciferase and β-galactosidase were determined as described under "Experimental procedures". In each experiment, luci-
ferase activity from transfected cells was normalized with the β-galactosidase activity and expressed as relative luciferase activ-
ities compared with the control (LexA only, lane 1). The error bar represents the mean ± S.D. from three independent 
experiments. B, diagrams of the reporter and the activator structures.BMC Cell Biology 2009, 10:9 http://www.biomedcentral.com/1471-2121/10/9
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GST (Glutathione S transferase) fusion protein pull-down 
assay
The expression and purification of GST, GST-Nrf1 deriva-
tives and GST-MCRS2 derivatives were all done following
the previous studies [45,46]. The S35-labled Nrf1 and
MCRS2 were made by in vitro transcription and transla-
tion method in reticulocyte lysate system according to the
manufacturer's manual (Promega). [35S] methionine
(Amersham Pharmacia Biotech) was transiently added in
the reaction for labelling the proteins and the templates
for these reactions were pcDNA3HA-Nrf1 and pRK5F-
MCRS2. 40 μl of 50% GST beads containing equal
amounts of each purified GST fusion protein were incu-
bated with S35-labled interested protein under 4°C for 2
hours in buffer D [20 mM Hepes, 100 mM KCl, 0.2 mM
EDTA, 20% glycerol, 1 mM PMSF, 1 mM dithiothreitol, 1
μg/μl BSA (bovine serum albumin, Promega)]. Then, the
beads were washed with 1 ml buffer D containing 200
mM salt (20 mM Hepes, 200 mM KCl, 0.2 mM EDTA,
20% glycerol, 1 mM PMSF, 1 mM DTT) for five times.
Bound proteins were eluted from the beads with 20 μl
buffer D containing 0.1 M reduced form glutathione [20
mM Hepes PH 8.0, 100 mM KCl, 0.2 mM EDTA, 20%
glycerol, and 0.1 M reduced form of glutathione (Sigma)]
under room temperature for 20 min. Finally, the proteins
in the elution supernatant were analyzed by SDS-polyacr-
ylamide gel electrophoresis and autoradiography.
Immunoprecipitation and western blotting
For determining the in vivo association of Nrf1 and
MCRS2 in mammalian cells, 10 ug of indicated
pcDNA3HA-Nrf1 and pRK5F-MCRS2 were co-transfected
into 293 cells with 50% confluent in 10-cm dish. After
transfection for 36 hours, the cells were washed once with
PBS (phosphate-buffered saline), lysed in 400 μl EBC lysis
buffer (420 mM NaCl, 50 mM NaF, 100 μM Na3VO4, 50
mM Tris pH8.0, 0.5% NP40, 1 mM EDTA, 5 mM MgCl2
and 1 mM PMSF), and rotated in eppendorff at 4°C for 30
min. Cellular debrises were pelleted by centrifugation at
18,000 × g for 15 min at 4°C. Whole cell lysates were
mixed with monoclonal antibody against FLAG M2, HA,
or mouse pre-immune serum, and then the immunocom-
plexes were mixed with 40 μl of protein G Sepharose
beads [50% slurry, washed beads with NETN buffer (25
mM Tris PH8.0, 50 mM NaCl, 0.5% sodium deoxycho-
late, 0.5% NP40) before use, Amersham Pharmacia Bio-
tech] and rotated in eppendorff at 4°C for 4 hours. The
beads were gently washed three times with 1 ml of wash
buffer (20 mM Tris PH8.0, 50 mM NaCl, 1 mM EDTA,
0.5% NP40, 5 mM MgCl2) followed by western blot anal-
ysis using anti-HA monoclonal antibody (Roche) and
anti-FLAG M2 monoclonal antibody (Sigma).
Cell culture, transfection and reporter gene assay
293 cells were maintained in DMEM (Dulbecco's modi-
fied Eagle's medium) containing 10% fetal bovine serum.
Approximately 2.4 × 106 cells were plated on 100 mm
dish 15 hours before transfection. Calcium phosphate-
mediated DNA transfection was performed on 293 cells as
described earlier [47]. Cell extracts were harvested 36
hours later for co-immunoprecipitation assays and west-
ern blot analysis. For the reporter gene assay, 293 cells
were plated at 4 × 105 per well (6-well plate) 12~15 hours
before transfection, and the cells received fresh medium 4
h before transfection. A luciferase reporter pGL3-control-
L6 contaning six LexA binding sites (0.2 ug), LexA-Nrf1
fusion protein expression plasmid (0.6 ug) and MCRS2
expression plasmid (0.5 ug) were cotransfected into 293
cells. The β-galactosidase expression plasmid, CMV-LacZ
(0.1 ug), was also included in this transfection as an inter-
nal control. Roughly 3 ug of total DNA/well was used in
each transfection procedure. Also, the total amounts of
DNA per well were kept constant after compensating with
the pRK5F empty vector. After DNA transfection for 36
hours, cells were harvested and examined for luciferase
activity according to the manufacturer's manual
(Promega). The data were expressed by normalization
with the internal control β-galactosidase activity. Each
experiment was performed in triplicate and the results
were presented as the means ± S.E. of at least three inde-
pendent experiments.
Immunofluorescence
293 and H1299 cells were seeded onto cover glasses at
about 50% confluence 24 hours before DNA transfection.
Cells were transfected with indicated plasmids expressing
HA-Nrf1 and MCRS2-FLAG by calcium phosphate
method. 36 hours after transfection, cells were fixed for 10
min with the fixation solution (4% paraformaldehyde
prepared in PBS) and then permeabilized with 0.4% Tri-
ton X-100. The fixed sample were then incubated with
anti-FLAG M2 Ab (Sigma) or anti-HA polyclonal Ab
(Santa Cruz Biotechnology) for 2 hours at room tempera-
ture and washed three times with PBS followed by incuba-
tion with FITC-conjugated anti-rabbit IgG (Jackson) for
HA-Nrf1 and Rhodamine-conjugated anti-mouse IgG
(Jackson) for MCRS2-FLAG for 1 hours. Cells were
observed under Nikon confocal laser microscopy with
excitation at 488 and emission at 543 nm, respectively.
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